Cargando…
Effects of miglustat treatment in a patient affected by an atypical form of Tangier disease
BACKGROUND: Tangier disease (TD) is a rare autosomal recessive disorder, resulting from mutations in the ATP binding cassette transporter (ABCA1) gene. The deficiency of ABCA1 protein impairs high density lipoprotein (HDL) synthesis and cholesterol esters trafficking. CASE REPORT: A 58 year-old fema...
Autores principales: | Sechi, Annalisa, Dardis, Andrea, Zampieri, Stefania, Rabacchi, Claudio, Zanoni, Paolo, Calandra, Sebastiano, De Maglio, Giovanna, Pizzolitto, Stefano, Maruotti, Valerio, Di Muzio, Antonio, Platt, Frances, Bembi, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172812/ https://www.ncbi.nlm.nih.gov/pubmed/25227739 http://dx.doi.org/10.1186/s13023-014-0143-3 |
Ejemplares similares
-
Profile of eliglustat tartrate in the management of Gaucher disease
por: Sechi, Annalisa, et al.
Publicado: (2016) -
Eye Movement Impairment Recovery in a Gaucher Patient Treated with Miglustat
por: Accardo, Agostino, et al.
Publicado: (2010) -
Myocardial fibrosis as the first sign of cardiac involvement in a male patient with Fabry disease: report of a clinical case and discussion on the utility of the magnetic resonance in Fabry pathology
por: Sechi, Annalisa, et al.
Publicado: (2014) -
The English hospital, Tangier, 1883-1908.
por: Sims, A C
Publicado: (1972) -
Current Diagnosis and Management of Tangier Disease
por: Koseki, Masahiro, et al.
Publicado: (2021)